Investors

Press Releases

Press Releases

Jan 25, 2022

Kymera Therapeutics to Participate in Upcoming January and February Investor Conferences

Jan 18, 2022

Kymera Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to Board of Directors

Jan 10, 2022

Kymera Therapeutics Announces Key 2022 Goals and Milestones to Support Its Evolution into a Fully Integrated Degrader Medicines Company

Jan 04, 2022

Kymera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022

Investor Contact

Bruce Jacobs, CFA, MBA
Chief Financial Officer
investors@kymeratx.com

Christopher F. Brinzey
Westwicke, an ICR Company for Kymera Therapeutics
chris.brinzey@westwicke.com
+ 1 339.970.2843

Media Contact

media@kymeratx.com

Tyler Gagnon
Director, Corporate Communications
tgagnon@kymeratx.com

Sign Up for Email Alerts